Platforms · Access · Governance

Organoid Grid

A publication about who builds the platforms that run computation on living tissue, who can actually get access to them, and who decides what is permissible. We read vendor claims against published specifications, and we take the governance questions as seriously as the engineering.

Daily analysis · 105 published · How this publication works

Several translucent brain organoids arranged in a clean laboratory rack, each resting on a microelectrode array under a faint green glow.
The platforms that make living neural tissue available to experimenters. Illustration.

Latest analysis

September 12, 2026 Selective persistence: engineering AAV episomes for durable gene expression
An NIGMS MIRA award to Ohio State studies why a small fraction of AAV genomes persists as episomes and whether the trick can be grafted onto synthetic delivery substrates. The answers will redraw who controls durable cell engineering and which oversight regime catches it.
September 12, 2026 Adaptive reservoir computing on integrated human brain organoids
An EFRI BEGIN OI award to the University of Michigan designs reservoir computers from integrated human brain organoids, with bioethicists embedded at every step. The architecture matters more than the results, and the results do not exist yet.
September 11, 2026 The NSF project that wants the public training brain organoids over the internet
An active NSF award to UC Santa Cruz designs a cloud-connected closed-loop platform for training human brain organoids on reinforcement-learning tasks, and then goes further: students and members of the public would run live experiments on the tissue over the internet. No results exist yet. The architecture itself is the finding, because it moves organoid access from institution-gated to platform-gated, and moves oversight with it.
September 11, 2026 Age-stratified gut chips and the quiet power of reference standards
A new NIA grant to the Jackson Laboratory builds an age-stratified gut-on-chip platform that pairs young and old donor-derived colon epithelia with their microbiomes. Only one capability is demonstrated so far: sustaining strictly anaerobic bacteria against organoid epithelium across a controlled oxygen gradient. That gradient, not the biology, is the vendor-grade spec, and the promised aging reference standards are a governance position as much as a product.
September 10, 2026 A CF core's service catalogue is the template for organoid access
A cystic fibrosis disease-model core at Cedars Sinai offers patient-derived organoids and commercial plus customized organ-on-chip services to investigators worldwide. Read as an access artefact, its service catalogue shows how platform capability, quality definitions, and redistribution logistics quietly concentrate in the core that runs them.
September 10, 2026 Variant-testing commons shows how organoid governance can be pre-committed
The UAB Childhood Cystic Kidney Disease Center couples high-throughput patient-variant testing in kidney organoids with an informatics resource that deposits every tool and dataset under DOIs in public repositories. The pairing of interpretive authority over 'functional variant' with open-by-design infrastructure is the governance lesson.
September 9, 2026 The liquid-handler problem nobody puts on the platform slide
A $250,000 NIH equipment grant to Vanderbilt's screening core exists to solve one unglamorous problem: getting temperature-sensitive, matrix-embedded cells out of a pipette and into 1536-well plates without wrecking them. The instrument being bought, MBD's ASFA Spotter, is a reminder that platform access is decided as much at the dispensing nozzle as at the bench, and that the access model is the shared core.

All analysis →

Start here

Standing explainers that do not go stale. Read the comparison first if this field is new to you.

Sections

How we work

We compare platforms on published specifications and peer-reviewed results, never on marketing copy, and we date every comparison because this market moves. Where a vendor funds or authors the work we are citing, we say so. On the ethics side we distinguish what is currently regulated from what is merely customary, and we do not present a philosophical position as a settled finding. The full method, including how pieces are selected and produced, is on the about page.